CSF NfL Levels Predict Cortical Atrophy in Early-Onset Alzheimer’s
Personalized briefing
Discovery of the day · Neurology
Relationships of CSF biomarkers to cortical atrophy in early‐onset Alzheimer’s disease
Dear Kelly M Leyden, this is your personalized scientific intelligence briefing — curated for your work in Neurology.
Key finding
Medicine · Neurology
Discovery of the day
In a cohort of 80 patients with early-onset Alzheimer’s disease (EOAD), researchers demonstrated that cerebrospinal fluid (CSF) neurofilament light chain (NfL) levels are the strongest predictor of cortical atrophy within the disease’s characteristic signature. Stepwise regression analyses showed that CSF NfL levels alone best predicted the magnitude of cortical thinning, outperforming seven other CSF biomarkers. These findings directly support your focus on blood-based proteomic biomarkers by validating CSF NfL as a clinically actionable indicator of neurodegenerative progression, while also demonstrating how a single protein biomarker can be correlated with multimodal imaging data to enhance prediction of cognitive decline.
Novelty
82%
Rigor
88%
Significance
90%
Validity
85%
Clarity
92%
Advertisement
ScientificChina — The Global Marketplace for Scientific and Medical Equipments Start Browsing →
Your briefing is personalized based on your selected fields, keywords, and research interests.
